The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 03, 2019

Filed:

Sep. 08, 2015
Applicant:

The Research Foundation for the State University of New York, Albany, NY (US);

Inventors:

Eckard Wimmer, East Setauket, NY (US);

Steffen Mueller, Kings Point, NY (US);

Bruce Futcher, Stony Brook, NY (US);

Sam Shen, Iowa City, IA (US);

Charles Stauft, Setauket, NY (US);

Charles Ward, San Jose, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 7/00 (2006.01); A61K 39/12 (2006.01); C12N 7/04 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C12N 7/00 (2013.01); A61K 39/12 (2013.01); C12N 7/04 (2013.01); A61K 2039/5254 (2013.01); C12N 2760/12221 (2013.01); C12N 2760/12233 (2013.01); C12N 2760/12234 (2013.01); C12N 2760/12262 (2013.01); C12N 2760/20062 (2013.01); C12N 2770/24121 (2013.01); C12N 2770/24122 (2013.01); C12N 2770/24134 (2013.01); C12N 2770/24162 (2013.01); C12N 2800/22 (2013.01); Y02A 50/386 (2018.01);
Abstract

This invention provides an attenuated virus comprising a modified viral genome engineered to containing multiple nucleotide substitutions that reduce the codon pair bias of a virus protein encoding sequence relative to a first host while the codon pair bias relative to a second host is not substantially reduced. In another embodiment, the invention provides an attenuated virus comprising modified viral genome engineered to containing multiple nucleotide substitutions that reduce the codon pair bias of a virus protein-encoding sequence relative to a first host and a second host. The attenuated virus may be used in a vaccine composition for inducing a protective immune response in a subject. The invention also provides a method of synthesizing the attenuated virus. Further, this invention further provides a method for preventing a subject from becoming afflicted with a virus-associated disease comprising administering to the subject a prophylactically effective dose of a vaccine composition comprising the attenuated virus.


Find Patent Forward Citations

Loading…